Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00496990 · ClinicalTrials.gov registry record · Phase 2

Treating the Partners of Drug Using Pregnant Women: Stage II

A Phase 2 study of Drug Addiction, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 2
Development phase
158
Enrollment target
1
Study location

NCT00496990 is a Phase 2 study of Drug Addiction that has completed, run by Johns Hopkins University. The registered enrollment target is 158 participants, above the 96-participant average among 13 other Drug Addiction trials with a reported enrollment target (65% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00496990, a Phase 2 study of Drug Addiction, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 2
Development phase
158 participants
Enrollment target
1
Study location

Study Summary

This is a two group randomized design that will compare a novel therapy package (i.e., Research supported treatment intervention, Contingency-based voucher incentives for the male partner's drug abstinence, Specialized MI couples counseling) to standard care for helping drug using partners of drug dependent pregnant women obtain and maintain drug abstinence. Participants will be followed for 22 weeks and have scheduled twice weekly urine sample collection and all participants will have follow-up interviews post-study entry.

Conditions Studied

Interventions

  • BEHAVIORAL control
  • BEHAVIORAL Enhanced care

Study Locations (1)

Maryland

  • Center for Addiction and Pregnancy Johns Hopkins Bayview Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2005-10
Est. Completion 2010-06
Phase Phase 2

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT00496990

The ClinicalTrials.gov registry entry for NCT00496990 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 13 other Drug Addiction trials with a reported enrollment target (65% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Drug Addiction appearing as the primary indexed condition, and to 2 interventions - of which control is the first listed.

NCT00496990 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00496990 about?

NCT00496990 is a clinical study titled "Treating the Partners of Drug Using Pregnant Women: Stage II". This is a two group randomized design that will compare a novel therapy package (i.e., Research supported treatment intervention, Contingency-based voucher incentives for the male partner's drug abstinence, Specialized MI couples counseling) to standard care for helping drug using partners of drug d...

What is the current status of trial NCT00496990?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 158 participants. The study started on 2005-10. Estimated completion is 2010-06.

What conditions does trial NCT00496990 study?

This clinical trial studies the following conditions: Drug Addiction.

What interventions are being tested in trial NCT00496990?

The interventions under investigation include: control (BEHAVIORAL), Enhanced care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00496990?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00496990 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Drug Addiction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.